# Comparative Study of the VeraCept Low-Dose Intrauterine Copper Contraceptive vs. the TCu380 Copper IUD

> **NCT02167763** · PHASE1 · COMPLETED · sponsor: **Sebela Women's Health Inc.** · enrollment: 300 (estimated)

## Conditions studied

- Prevention of Pregnancy

## Interventions

- **DEVICE:** VeraCept Intrauterine Copper Contraceptive
- **DEVICE:** TCu380 IUD

## Key facts

- **NCT ID:** NCT02167763
- **Lead sponsor:** Sebela Women's Health Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-11
- **Primary completion:** 2014-12
- **Final completion:** 2017-12-31
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2022-04-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02167763

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02167763, "Comparative Study of the VeraCept Low-Dose Intrauterine Copper Contraceptive vs. the TCu380 Copper IUD". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02167763. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*